Collectively, these findings indicate that RGMa expression is associated with CCH-induced cognitive decline by enhancing hippocampal pathology rather than white matter pathology, and that the anti-RGMa antibody exerts its therapeutic effect by normalizing hippocampal neurogenesis and cholinergic innervation. Here, RGMA is linked to columnar cell hyperplasia of the breast.